Cost of HIV and determinants of health care costs in HIV-positive patients in Germany – Results of the DAGNÄ K3A Study
Mostardt, S.; Hanhoff, N.; Wasem, J.; Goetzenich, A.; Schewe, K.; Mayr, C.; Jäger, H.; Wolf, E.; Dupke, S.; Neumann, A. · Das Gesundheitswesen · 2011 · Heft 8/09 · S. 1 bis 1
Bibliografische Angaben
Zusammenfassung
The rising prevalence of human immunodeficiency virus (HIV)-infection in Germany leads to an increasing health economic burden. However there is a lack of nation-wide data on the current medical and societal costs of HIV and AIDS. Objectives: The aims of this study were to estimate the medical expenditures for HIV-care in Germany and to identify variables associated with resource use. Methods: We performed an 18-months prospective multi-centre study in an HIV-specialized ambulatory care setting from 2006–2009. All health care costs were estimated following a bottom-up approach from two perspectives: 1) those inc…
